Global Blood Therapeutics Inc (GBT):企業の財務・戦略的SWOT分析

◆英語タイトル:Global Blood Therapeutics Inc (GBT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH418099FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company’s lead drug candidate GBT440 is an oral, small molecule drug for the treatment of sickle cell disease. Its GBT440 is a hemoglobin modifier which targets the mechanism of red blood cell sickling for the treatment of SCD. GBT’s pipeline also includes an oral kallikrein inhibitor to prevent hereditary angioedema attacks. The company also develops therapies which are in preclinical and preliminary clinical stage for the treatment of for acute and chronic hypoxemic pulmonary disorders. It offers chemical and biological mechanisms of blood-based disorders. GBT is headquartered in South San Francisco, California, the US.

Global Blood Therapeutics Inc Key Recent Developments

Apr 08,2021: Complete 72-Week Results from Phase 3 HOPE Study of Oxbryta® (voxelotor) Tablets Published in The Lancet Haematology Show Significantly Improved Hemoglobin, Hemolysis and Overall Health Status in Sickle Cell Disease Patients
Mar 02,2021: GBT opens 2021 ACCEL grant program, providing up to $500,000 in support to the sickle cell disease community

This comprehensive SWOT profile of Global Blood Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Global Blood Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Global Blood Therapeutics Inc – Key Information
Global Blood Therapeutics Inc – Overview
Global Blood Therapeutics Inc – Key Employees
Global Blood Therapeutics Inc – Key Employee Biographies
Global Blood Therapeutics Inc – Key Operational Heads
Global Blood Therapeutics Inc – Major Products and Services
Global Blood Therapeutics Inc – History
Global Blood Therapeutics Inc – Company Statement
Global Blood Therapeutics Inc – Locations And Subsidiaries
Global Blood Therapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Global Blood Therapeutics Inc – Business Description
Global Blood Therapeutics Inc – Corporate Strategy
Global Blood Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Global Blood Therapeutics Inc – Strengths
Global Blood Therapeutics Inc – Weaknesses
Global Blood Therapeutics Inc – Opportunities
Global Blood Therapeutics Inc – Threats
Global Blood Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Global Blood Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Global Blood Therapeutics Inc, Key Information
Global Blood Therapeutics Inc, Key Ratios
Global Blood Therapeutics Inc, Share Data
Global Blood Therapeutics Inc, Major Products and Services
Global Blood Therapeutics Inc, History
Global Blood Therapeutics Inc, Key Employees
Global Blood Therapeutics Inc, Key Employee Biographies
Global Blood Therapeutics Inc, Key Operational Heads
Global Blood Therapeutics Inc, Other Locations
Global Blood Therapeutics Inc, Subsidiaries
Global Blood Therapeutics Inc, Key Competitors
Global Blood Therapeutics Inc, SWOT Analysis
Global Blood Therapeutics Inc, Ratios based on current share price
Global Blood Therapeutics Inc, Annual Ratios
Global Blood Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Global Blood Therapeutics Inc (GBT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Spineology Inc-医療機器分野:企業M&A・提携分析
    Summary Spineology Inc (Spineology) is a medical device company that develops and designs spinal implants. The company offers products such as pedicular fixation system, interbody fusion system, deployable grafting system, amniotic fixation system, allografts, retractor system, liquid tissue matrix, …
  • PT Cikarang Listrindo (POWR):電力:M&Aディール及び事業提携情報
    Summary PT Cikarang Listrindo (Cikarang Listrindo) is a power company that generates and distributes electricity. The company offers services such as 24hours customer hotline, well trained security team, substation maintenance and calibration of kilo watt hour meters. It caters to automobile, electr …
  • Massmart Holdings Limited (MSM):企業の財務・戦略的SWOT分析
    Massmart Holdings Limited (MSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Assa Abloy AB:企業のM&A・事業提携・投資動向
    Assa Abloy AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Assa Abloy AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Cyalume Technologies Holdings, Inc.:企業の戦略・SWOT・財務情報
    Cyalume Technologies Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cyalume Technologies Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Repower AG:電力:M&Aディール及び事業提携情報
    Summary Repower AG (Repower), formerly Ratia Energie AG is an energy company that produces, transmits and distributes electricity. The company's services include trading, market access, and sales support services. It generates electric energy from hydropower, wind power plants, and combined-cycle ga …
  • West Pharmaceutical Services Inc (WST):企業の財務・戦略的SWOT分析
    West Pharmaceutical Services Inc (WST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • ArcelorMittal:企業のM&A・事業提携・投資動向
    ArcelorMittal - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ArcelorMittal Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Guess Inc (GES):企業の財務・戦略的SWOT分析
    Guess Inc (GES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Hunan Fangsheng Pharmaceutical Co Ltd (603998):製薬・医療:M&Aディール及び事業提携情報
    Summary Hunan Fangsheng Pharmaceutical Co Ltd (Fangsheng Pharma) is a research-based comprehensive pharmaceutical enterprise offers research, development, manufacturing and sales of pharmaceuticals. The enterprise’ products include tablets, capsules, granules, oral suspension, powder, suppository, p …
  • Television Francaise 1 SA:企業の戦略・SWOT・財務情報
    Television Francaise 1 SA - Strategy, SWOT and Corporate Finance Report Summary Television Francaise 1 SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • HearMeOut Ltd (HMO):企業の財務・戦略的SWOT分析
    HearMeOut Ltd (HMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • British Columbia Investment Management Corp:企業の戦略的SWOT分析
    British Columbia Investment Management Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • IACInterActiveCorp (IAC):企業の財務・戦略的SWOT分析
    IACInterActiveCorp (IAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Regal Petroleum Plc (RPT):石油・ガス:M&Aディール及び事業提携情報
    Summary Regal Petroleum Plc (Regal), a subsidiary of Energees Investments Ltd, is an oil and gas company that conducts reviews on oil and gas projects. The company operates two gas and condensate fields such as Mekhediviska - Golotovschinska and Svyrydivske located in Dneipner-Donets basin in the no …
  • Myer Holdings Ltd:戦略・SWOT・企業財務分析
    Myer Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Myer Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Chembio Diagnostic, Inc. (CEMI)-医療機器分野:企業M&A・提携分析
    Summary Chembio Diagnostic, Inc. (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP), which makes P …
  • Laboratoires Pierre Fabre SA:企業の戦略的SWOT分析
    Laboratoires Pierre Fabre SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • SBS Transit Ltd.:企業の戦略・SWOT・財務情報
    SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report Summary SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Genomic Health Inc (GHDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆